1Antonicelli R, Sardina M, Scotti A, et al. Randomized trial of the effects of low-dose calcium-heparin in patients with peripheral arterial disease and claudication. Italian CAP Study Group [J]. AmJ Med, 1999; 107(3):234
2Kalani M, Apelqvist J, Blomback M, et al. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study [J]. Diabetes Care, 2003; 2
3Nowakowski FS, Freeman HJ. Endovascular therapy for atherosclerotic occlusion and stenosis from the infrarenal aorta to the infrapopliteal arteries [J]. Mt Sinai J Med, 2003; 70(6) : 393
4Ouriel K. Peripheral arterial disease [J]. Lancet, 2001; 358(9289): 1257
5Forrester JS, Price MJ, Makkar RR. Stem cell repair of infarcted myocardium: an overview for clinicians [J]. Circulation,2003; 108(9): 1139
6Dotter CT, Judkins MP. Transluminal Treatment of arteriosclerotic Obstruction. Description of a new technic and a preliminary report of its application [J]. Circulation, 1964; 30(4):654
7Kensey KR, Nash JE, Abrahams C, et al. Recanalization of obstructed arteries with a flexible, rotating tip catheter [J].Radiology, 1987; 165(2) : 387
8Morishita R. Recent progress in gene therapy for cardiovascular disease [J]. CircJ, 2002; 66(12):1077
9Emanueli C, Madeddu P. Angiogenesis gene therapy to rescue ischaemic tissues: achievements and future directions [J]. Br J Pharmacol, 2001; 133(7): 951
10Morishita R, Aoki M, Kaneda Y, et al. Gene therapy in vascular medicine: recent advances and future perspectives [J].Pharmacol Ther, 2001; 91(2): 105
